KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ZOM
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Zomedica stock price ended at $0.133 on Friday, after gaining 2.23%.
(Updated on Apr 26, 2024)

Buy or Hold candidate since Apr 22, 2024 Gain 2.23% PDF

The Zomedica stock price gained 2.23% on the last trading day (Friday, 26th Apr 2024), rising from $0.130 to $0.133. During the last trading day the stock fluctuated 1.82% from a day low at $0.132 to a day high of $0.134. The price has fallen in 6 of the last 10 days and is down by -1.48% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 1 million more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately $337.67 thousand.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 3.25% during the next 3 months and, with a 90% probability hold a price between $0.128 and $0.163 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ZOM Signals & Forecast

A buy signal was issued from a pivot bottom point on Friday, April 19, 2024, and so far it has risen 7.52%. Further rise is indicated until a new top pivot has been found. Zomedica has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Zomedica stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.136. On a fall, the stock will find some support from the short-term average at $0.130. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Zomedica stock

Zomedica finds support from accumulated volume at $0.130 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0024 between high and low, or 1.82%. For the last week, the stock has had daily average volatility of 3.88%.

Our recommended stop-loss: $0.127 (-4.28%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 5 days ago.)

Trading Expectations (ZOM) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Zomedica Pharmaceuticals Corp to open at $0.133, and during the day (based on 14 day Average True Range), to move between $0.127 and $0.139, which gives a possible trading interval of +/-$0.0062 (+/-4.64%) up or down from last closing price. If Zomedica Pharmaceuticals Corp takes out the full calculated possible swing range there will be an estimated 9.27% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.130 (2.11%) than the resistance at $0.136 (2.56%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Zomedica Pharmaceuticals Corp stock A Buy?

Zomedica holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: -0.549 Hold/Accumulate Unchanged

Predicted Opening Price for Zomedica Pharmaceuticals Corp of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$0.133 ( 0.0501%) $0.133

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ZOM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.135 1.85 %
R2 0.135 1.17 %
R1 0.134 0.739 %
Current price: 0.133
Support S1 0.132 -0.639 %
S2 0.132 -1.07 %
S3 0.131 -1.75 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.155 16.54 %
R2 0.140 5.26 %
R1 0.136 2.56 %
Current price 0.133
Support S1 0.130 -2.11%
S2 0.123 -7.89%
S3 0.120 -9.77%

FAQ

What is the symbol for Zomedica Stock and on which exchange is it traded?
The symbol for Zomedica is ZOM and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell Zomedica Stock?
Zomedica holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Zomedica Stock?
Zomedica Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Zomedica Stock.

What's the current price of Zomedica Stock?
As of the end of day on the Apr 26, 2024, the price of an Zomedica (ZOM) share was $0.133.

What is the 52-week high and low for Zomedica Stock?
The 52-week high for Zomedica Stock is $0.245 and the 52-week low is $0.120.

What is the market capitalization of Zomedica Stock?
As of the Apr 26, 2024, the market capitalization of Zomedica is 127.491M.

When is the next earnings date for Zomedica?
The upcoming earnings date for Zomedica is Aug 08, 2024.
Click to get the best stock tips daily for free!

About Zomedica Pharmaceuticals Corp

Zomedica Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and ... ZOM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT